ArticleClinical and translational medicine2025

Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non-small-cell lung cancer.

Yong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.